Leiden Improvement of MIgraine Therapy in general practice.

Triptan overuse in migraine in primary care, a proactive approach.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON24827

Enrollment

600

Registered

2006-12-13

Start date

2007-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

Proactive stepped approach based on the Dutch GP Guideline versus usual care. Step 1: a letter to invite patients for consultation. Step 2: a visit to the GP, who can give information about headache a

Eligibility

Inclusion criteria

Inclusion criteria: Patients in general practice using ¡Ý24 DDD triptans (or ¡Ý6 DDDs in the last 3 months), enlisted in 60 general practices, that are part of LEON (the Leiden Eerstelijns Onderzoeksnetwerk, managed by the department of Public Health and Primary Care).

Exclusion criteria

Exclusion criteria: 1. Younger than 18 years; 2. Cognitive impairment; 3. Psychiatric illness; 4. Terminal illness; 5. Non-Dutch speaking.

Design outcomes

Primary

Measure	Time frame
HIT-6 (Headache Impact Test)-score at baseline and after 3, 6, 9 and 12 months.	—

Secondary

Measure	Time frame
1. The health-related quality of life (self reported EQ-5D and visual analogue scale); 2. Migraine characteristics; 3. Medication use; 4. Social effects of migraine including absence at work. Measured at baseline and after 3, 6, 9 and 12 months.	—

Contacts

Public ContactJ.W. Blom

Leiden University Medical Center (LUMC), Department of Public Health and Primary Care, Postzone V-0-P, P.O. Box 9600

J.W.Blom@lumc.nl+31 (0)71 5268406

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)